Ultima-Ipamorelin 10mg

Manufacturer: Ultima Pharmaceuticals

Pharmaceutical name: Ipamorelin

Pack: 1 vial (10 mg)

Ipamorelin is an intriguing new discovery in muscle building that is garnering significant attention in the bodybuilding community. Similar to the GHRP-6 peptide (growth hormone releasing hexapeptide), it is a synthetic peptide with potent Growth Hormone releasing capabilities. These GH releasing traits are particularly appealing to athletes and bodybuilders, as they can significantly enhance muscle growth and accelerate fat loss.

 

Athletes typically administer Ipamorelin in a dosage of 200mcg to 300mcg, two or three times a day, using a small insulin syringe for injection. They often begin with a lower dose because side effects may include headaches or sensations resembling a head-rush. Ipamorelin can be used at any time, but taking it approximately 30-45 minutes prior to a workout is thought to be optimal due to the Growth Hormone (GH) spike it induces, which maximizes growth potential.

 

Research regarding the impact of Ipamorelin on bone growth, body weight, and GH release has yielded some noteworthy findings.

 

In one study, various doses were administered over 15 days to observe the group's responses.

 

A clear and dose-dependent impact on body weight gain was noted; however, the treatment group did not exhibit variations in total IGF-I levels. Additionally, no serum markers for bone development were produced by the treatment group. For instance, there was no significant change in the number of cells in the tibia's wide section (the shinbone). This is positive, as it indicates muscle growth without an increased risk of bone or cartilage deformities.

 

The pituitary's response to a substantial intravenous dose of Ipamorelin revealed that plasma GH levels were significantly decreased, while levels remained unchanged after a similar dose of GHRH. This is actually favorable as it implies that Ipamorelin may not inhibit the body's natural GH production, further confirming that Ipamorelin acts as a selective GH releaser.